Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

14.04 -0.61 (-4.13%)
Streaming Delayed Price Updated: 9:41 AM EDT, Aug 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 239,467
Open 14.60
Bid (Size) 14.01 (100)
Ask (Size) 14.07 (200)
Prev. Close 14.64
Today's Range 14.01 - 14.71
52wk Range 4.400 - 15.40
Shares Outstanding 41,695,335
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
COMPASS Pathways (CMPS) Q2 2026 Earnings Call Transcript ↗
COMP360 shows 39% response rate; commercial launch targeted for H1 2027. 
Via The Motley Fool
Topics Earnings
News headline image
Compass Pathways Targets 2027 COMP360 Launch as FDA Filing Advances ↗
Compass Pathways (NASDAQ:CMPS) said it remains on track to complete a new drug application for COMP360, its investigational psilocybin treatment for treatment-resistant depression, in the fourth... 
Via MarketBeat
Topics Government

Performance

YTD
+114.3%
+114.3%
1 Month
+29.4%
+29.4%
3 Month
+17.7%
+17.7%
6 Month
+91.5%
+91.5%
1 Year
+197.4%
+197.4%

More News

Read More
News headline image
Compass Pathways to Participate in Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026
From Compass Pathfinder Limited
Via Business Wire
Compass Pathways (NASDAQ:CMPS) Shares Plunge 42% After Q2 Report Despite Narrower-Than-Expected Loss ↗
Via Chartmill
News headline image
Compass Pathways Working with U.S. Department of Veterans Affairs for Investigational Study of Psilocybin
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Compass Pathfinder Limited
Via Business Wire
News headline image
A CEO With a Proven Track Record of Success in Growing and Scaling Biopharmaceutical Companies Just Appointed CEO at a Clinical-Stage Biotech, Months Before Its Pivotal Phase 3 Readout
From USA News Group
Via GlobeNewswire
News headline image
Compass Pathways Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Cannabis Earnings Government
News headline image
Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways to Announce Second Quarter and First Half 2026 Financial Results on August 5, 2026
From Compass Pathfinder Limited
Via Business Wire
News headline image
Eli Lilly Is Acquiring AtaiBeckley for $2.8 Billion. Cathie Wood Thinks Another Psychedelic Drug Stock Is an Even Better Bet. ↗
Via The Motley Fool
Topics ETFs Government
News headline image
Eli Lilly Is Acquiring a Psychedelic Medicine Biotech. Here's What You Need to Know. ↗
Via The Motley Fool
News headline image
Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates
Via FinancialNewsMedia
Topics Artificial Intelligence
News headline image
Compass Pathways Announces Publication of Post-Hoc Analysis Demonstrating Distinction of COMP360 Trial Monitoring & Support from Psychotherapy
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways Eyes 2027 Launch as Psilocybin Depression Data Holds Up ↗
Via MarketBeat
Topics Cannabis Government
News headline image
Compass Pathways Announces Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Compass Pathfinder Limited
Via Business Wire
News headline image
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity
Via FinancialNewsMedia
News headline image
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity
From MarketNewsUpdates.com
Via GlobeNewswire
News headline image
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways Elects Kathleen Tregoning to Board of Directors
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 2026
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass Pathways Eyes Q4 FDA Filing for Psilocybin Depression Drug After Phase 3 Wins ↗
Via MarketBeat
Topics Cannabis Government
News headline image
Compass Pathways to Participate in RBC Capital Markets Global Healthcare Conference on May 19-20, 2026
From Compass Pathfinder Limited
Via Business Wire
News headline image
Compass (CMPS) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
Topics Earnings

Frequently Asked Questions

Is COMPASS Pathways Plc - American Depository Shares publicly traded?
Yes, COMPASS Pathways Plc - American Depository Shares is publicly traded.
What exchange does COMPASS Pathways Plc - American Depository Shares trade on?
COMPASS Pathways Plc - American Depository Shares trades on the Nasdaq Stock Market
What is the ticker symbol for COMPASS Pathways Plc - American Depository Shares?
The ticker symbol for COMPASS Pathways Plc - American Depository Shares is CMPS on the Nasdaq Stock Market
What is the current price of COMPASS Pathways Plc - American Depository Shares?
The current price of COMPASS Pathways Plc - American Depository Shares is 14.04
When was COMPASS Pathways Plc - American Depository Shares last traded?
The last trade of COMPASS Pathways Plc - American Depository Shares was at 08/28/26 09:41 AM ET
What is the market capitalization of COMPASS Pathways Plc - American Depository Shares?
The market capitalization of COMPASS Pathways Plc - American Depository Shares is 585.19M
How many shares of COMPASS Pathways Plc - American Depository Shares are outstanding?
COMPASS Pathways Plc - American Depository Shares has 585M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.